4.7 Article

Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson's disease

期刊

SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-017-12947-7

关键词

-

资金

  1. Michael J. Fox Foundation for Parkinson's Research
  2. Abbott
  3. Avid Radiopharmaceuticals
  4. Biogen Idec
  5. Bristol-Myers Squibb
  6. Covance
  7. GE Healthcare
  8. Genentech
  9. GSK-GlaxoSmithKline
  10. Lundbeck
  11. Lilly
  12. Merck
  13. MSD-Meso Scale Discovery
  14. Pfizer
  15. Piramal
  16. Roche
  17. Sanofi Genzyme
  18. Servier
  19. Teva
  20. UCB
  21. Singapore National Research Foundation [TCR12dec010, NMRC/CNIG/1160/2016]

向作者/读者索取更多资源

Olfactory dysfunction is a robust and early sign for Parkinson's disease (PD). Previous studies have revealed its association with dementia and related neural changes in PD. Yet, how olfactory dysfunction affects white matter (WM) microstructure in newly diagnosed and untreated PD remains unclear. Here we comprehensively examined WM features using unbiased whole-brain analyses. 88 newly diagnosed PD patients without dementia (70 with hyposmia and 18 without hyposmia) and 33 healthy controls underwent clinical assessment and diffusion tensor imaging (DTI) scanning. Tract-based special statistics (TBSS), graph-theoretic methods and network-based statistics (NBS) were used to compare regional and network-related WM features between groups. TBSS analysis did not show any differences in fractional anisotropy and mean diffusivity between groups. Compared with controls, PD patients without hyposmia showed a significant decrease in global efficiency, whilst PD patients with hyposmia exhibited significantly reduced global and local efficiency and additionally a disrupted connection between the right medial orbitofrontal cortex and left rectus and had poorer frontal-related cognitive functioning. These results demonstrate that hyposmia-related WM changes in early PD only occur at the network level. The confined disconnectivity between the bilateral olfactory circuitry may serve as a biomarker for olfactory dysfunction in early PD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据